L2L L2L Microarray Analysis Tool

Results for L04A.profile.d50

Results summary View all lists in GO:BiolProc View all genes in L04A.profile.d50
List Name Description Total
probes
Expected
matches
Actual
matches
Fold
Enrichment
Binomial
p-value
polyamine biosynthetic process The chemical reactions and pathways resulting in the formation of polyamines, any organic compound containing two or more amino groups. 9 0.02 2 89.90 2.17e-04
polyamine metabolic process The chemical reactions and pathways involving polyamines, any organic compound containing two or more amino groups. 17 0.04 2 47.59 8.11e-04
amine biosynthetic process The chemical reactions and pathways resulting in the formation of any organic compound that is weakly basic in character and contains an amino or a substituted amino group. Amines are called primary, secondary, or tertiary according to whether one, two, or three carbon atoms are attached to the nitrogen atom. 94 0.23 3 12.91 1.71e-03
establishment and/or maintenance of chromatin architecture The specification, formation and maintenance of the physical structure of eukaryotic chromatin. 365 0.90 5 5.54 2.33e-03
DNA packaging Any process by which DNA and associated proteins are formed into a compact, orderly structure. 371 0.92 5 5.45 2.49e-03
histone acetylation The modification of histones by addition of acetyl groups. 31 0.08 2 26.10 2.71e-03
amino acid derivative metabolic process The chemical reactions and pathways involving compounds derived from amino acids, organic acids containing one or more amino substituents. 115 0.28 3 10.55 3.03e-03
ribonucleoprotein complex biogenesis and assembly The cellular process by which a complex containing RNA and proteins, is synthesized, aggregates, and bonds together. 239 0.59 4 6.77 3.12e-03
biogenic amine biosynthetic process The chemical reactions and pathways resulting in the formation of any of a group of naturally occurring, biologically active amines, such as norepinephrine, histamine, and serotonin, many of which act as neurotransmitters. 36 0.09 2 22.47 3.64e-03
nitrogen compound biosynthetic process The chemical reactions and pathways resulting in the formation of organic and inorganic nitrogenous compounds. 132 0.33 3 9.19 4.46e-03
protein amino acid acetylation The addition of an acetyl group to a protein amino acid. An acetyl group is CH3CO-, derived from acetic [ethanoic] acid. 40 0.10 2 20.23 4.48e-03
response to hypoxia A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. 43 0.11 2 18.82 5.16e-03
amino acid derivative biosynthetic process The chemical reactions and pathways resulting in the formation of compounds derived from amino acids, organic acids containing one or more amino substituents. 46 0.11 2 17.59 5.88e-03
cell cycle phase A cell cycle process comprising the steps by which a cell progresses through one of the biochemical and morphological phases and events that occur during successive cell replication or nuclear replication events. 474 1.17 5 4.27 6.95e-03
chromosome organization and biogenesis (sensu Eukaryota) A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of eukaryotic chromosomes, structures composed of a very long molecule of DNA and associated proteins (e.g. histones) that carries hereditary information. As in, but not restricted to, the eukaryotes (Eukaryota, ncbi_taxonomy_id:2759). 477 1.18 5 4.24 7.13e-03
protein amino acid acylation The addition of an acyl group, any group or radical of the form RCO- where R is an organic group, to a protein amino acid. 52 0.13 2 15.56 7.46e-03
chromosome organization and biogenesis A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of chromosomes, structures composed of a very long molecule of DNA and associated proteins that carries hereditary information. 493 1.22 5 4.10 8.15e-03
DNA damage checkpoint A signal transduction pathway, induced by DNA damage, that blocks cell cycle progression (in G1, G2 or metaphase) or slows the rate at which S phase proceeds. 57 0.14 2 14.19 8.91e-03

Raw data (tab-delimited .txt)